Xconomy’s Digital Events →
December 3, 2020 · New York
Stanley Lapidus is the president, CEO, and founder of SynapDx
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.